Phase of Development: Hit to Lead

Mechanism of Action: Tau Proteostasis, Propagation and Clearance

Compound Type/Modality: Vaccine

Active Vaccine for Tauopathy

Marc Diamond, MD

Professor, UT Southwestern Medical Center (Dallas, TX)

For further information about this program Contact: